This inventor holds 1 USPTO granted patent. Top assignee: Columbia University. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Jameel A. Feshitan: Innovator in Medical Imaging Technology
Introduction
Jameel A. Feshitan is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of medical imaging, particularly through his innovative patent related to contrast devices. His work is essential for advancing imaging techniques that enhance patient care.
Latest Patents
Jameel A. Feshitan holds a patent for "Medical imaging contrast devices, methods, and systems." This patent involves systems, methods, and devices for generating and using size-selected lanthanide-coated microbubbles. These microbubbles are utilized for controlling an imaging signal via microbubble fragmentation and for magnetic resonance imaging-guided focused ultrasound therapy. This invention represents a significant advancement in medical imaging technology.
Career Highlights
Feshitan is affiliated with Columbia University, where he continues to engage in research and development in the field of medical imaging. His work at the university allows him to collaborate with other experts and contribute to groundbreaking advancements in healthcare technology.
Collaborations
Some of Jameel A. Feshitan's notable coworkers include Mark A. Borden and Elisa E. Konofagou. Their collaborative efforts enhance the research environment and foster innovation in medical imaging.
Conclusion
Jameel A. Feshitan is a key figure in the development of medical imaging technologies, with a focus on improving patient outcomes through innovative solutions. His contributions are vital to the ongoing evolution of medical imaging practices.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
